Miransertib mesylate is a selective AKT inhibitor that binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. This may result in reduction in tumor cell proliferation and the induction of tumor cell apoptosis.
Molecular Weight:
624.73
CAS Number:
[1817727-88-0]
Formula:
C29H32N6O6S2
Target:
Others
T70152
* VAT and and shipping costs not included. Errors and price changes excepted